Tizanidine Hcl

Basic Information

Item Value
DrugBank ID DB00697
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 migraine disorder KG + DL
2 migraine with brainstem aura KG + DL
3 migraine with or without aura, susceptibility to KG + DL
4 atrophoderma vermiculata KG + DL
5 Tourette syndrome KG + DL
6 ulerythema ophryogenesis KG + DL
7 trichotillomania KG + DL
8 headache disorder KG + DL
9 dysthymic disorder KG + DL
10 fibromyalgia KG + DL
11 tendinitis KG + DL
12 sciatic neuropathy KG + DL
13 idiopathic granulomatous myositis KG + DL
14 myositis fibrosa KG + DL
15 open-angle glaucoma KG + DL
16 rheumatoid arthritis KG + DL
17 primary hereditary glaucoma KG + DL
18 trigeminal autonomic cephalalgia KG + DL
19 inclusion body myositis KG + DL
20 pulmonary hypertension KG + DL
21 nephrogenic syndrome of inappropriate antidiuresis KG + DL
22 brachydactyly-syndactyly syndrome KG + DL
23 kyphoscoliotic heart disease KG + DL
24 myofascial pain syndrome KG + DL
25 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
26 anaphylaxis KG + DL
27 congenital hypotrichosis milia KG + DL
28 hypotrichosis simplex of the scalp KG + DL
29 erectile dysfunction (disease) KG + DL
30 diffuse alopecia areata KG + DL
31 obsolete vascular headache KG + DL
32 alopecia KG + DL
33 anxiety disorder KG + DL
34 exostosis KG + DL
35 monogenic obesity KG + DL
36 glossodynia KG + DL
37 coccygodynia KG + DL
38 food-dependent exercise-induced anaphylaxis KG + DL
39 methemoglobinemia, alpha type KG + DL
40 methemoglobinemia KG + DL
41 common cold KG + DL
42 obesity disorder KG + DL
43 benign paroxysmal torticollis of infancy KG + DL
44 glaucoma 1, open angle KG + DL
45 amenorrhea (disease) KG + DL
46 attention deficit-hyperactivity disorder KG + DL
47 methemoglobin reductase deficiency KG + DL
48 asthma-related traits, susceptibility to KG + DL
49 progressive supranuclear palsy KG + DL
50 allergic asthma KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.